{"id":866133,"date":"2025-07-02T09:26:04","date_gmt":"2025-07-02T13:26:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/"},"modified":"2025-07-02T09:26:04","modified_gmt":"2025-07-02T13:26:04","slug":"inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/","title":{"rendered":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase"},"content":{"rendered":"<div class=\"mw_release\">\n<p>RA&#8217;ANANA, Israel, July  02, 2025  (GLOBE NEWSWIRE) &#8212; Inspira\u2122 Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (&#8220;<strong>Inspira,<\/strong>&#8221; <strong>\u201cInspira Technologies,\u201d<\/strong> or the &#8220;<strong>Company<\/strong>&#8220;), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside the United States, in a global strategic hub, with an established track record and active commercial ties to both government entities and institutional healthcare customers. <\/p>\n<p>Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025. Inspira and the purchasing organization have initiated onboarding, logistics planning, and deployment scheduling, with immediate implementation.<\/p>\n<p>This purchase order is a significant commercial milestone for Inspira, marking a clear transition into full-scale revenue generation. Inspira estimates that this purchase order represents only a small portion of the total addressable market the Company is currently targeting globally.<\/p>\n<p>&#8220;We view this order as a signal of the broad activation of Inspira\u2019s commercial model,\u201d said Dagi Ben-Noon, CEO of Inspira Technologies. \u201cIt is a vote of confidence in our technology, confirms market demand, and signals to the market that we are executing in real-world settings. The clinical use of the ART100 in top U.S. medical centers opened the door to this agreement, and it lays the foundation for the next wave of global deployments already underway.\u201d<\/p>\n<p>Inspira is currently in advanced negotiations with additional healthcare companies and governmental institutions across multiple regions. These discussions are progressing toward commercial agreements that are expected to be announced in the near term, further supporting the Company\u2019s commercial expansion strategy.<\/p>\n<p>This announcement follows a series of major company milestones, including successful clinical integration in Tier-1 hospitals, and manufacturing expansion. Inspira is actively scaling its commercial infrastructure to support accelerated pipeline expansion and recurring deployments on a global scale.<\/p>\n<p>\n        <strong>About Inspira Technologies<\/strong>\n      <\/p>\n<p>Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The Company\u2019s U.S. Food and Drug Administration -cleared INSPIRA\u2122 ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S and serves as a foundation for the development of the INSPIRA ART500 \u2014 a next-generation system designed to deliver oxygenation while patients remain awake and spontaneously breathing. Inspira Technologies is also advancing HYLA\u2122, a proprietary blood sensor platform offering continuous, non-invasive monitoring. With multiple cleared products, a growing IP portfolio, and strategic streamlining of its operations, Inspira Technologies is increasingly positioned as an attractive platform within the life-support and MedTech landscape. The Company\u2019s recent internal shifts may reflect broader alignment with long-term industry trends, including consolidation, cross-sector collaboration, and potential strategic partnerships. For more information, visit: https:\/\/inspira-technologies.com<\/p>\n<p>\n        <strong>Forward-Looking Statement Disclaimer<\/strong>\n      <\/p>\n<p>This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected receipt of payment under the purchase order, and the timing of such payment, the commencment of the onboarding, logistics planning, and deployment scheduling, the Company\u2019s belief that this purchase order is a significant commercial milestone for the Company, the Company\u2019s estimation that the purchase order represents only a small portion of the total addressable market the Company is currently targeting globally, the Company\u2019s statement that the purchase order is a signal of the broad activation of the Company\u2019s commercial model, that the purchase order is a vote of confidence in its technology, confirms market demand, and signals to the market that the Company is\u00a0 executing in real-world settings, that the clinical use of the ART100 in top U.S. medical centers opened the door to the purchase order and lays the foundation for the next wave of anticipated global deployments already underway, that the Company\u2019s discussions with additional healthcare companies and governmental institutions are progressing towards commercial agreements that are expected to be announced in the near term, further supporting the Company\u2019s commercial expansion strategy, and that the Company is actively scaling its commercial infrastructure to support accelerated pipeline expansion and recurring deployments on a global scale. These forward-looking statements and their implications are based solely on the current expectations of the Company&#8217;s management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 20-F for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), which is available on the SEC&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=99QsMVOumq2KDwepkVufAqxL0lGlswLt2oYEVXSCz1nn-6ImRZ9d7zdnnL3PW4MhwFd-54rQV-kPKy2sWJG8Fw==\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>.<\/p>\n<p>\n        <strong>Company Contact<br \/><\/strong>Inspira Technologies \u2013 Media Relations<br \/>Email: info@inspirao2.com<br \/>Phone: +972-9-9664485<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDM5NWJjNmMtZDRhNC00M2NlLTk4NTktMmVhZDhkNGI0ZjRmLTEyMjI1ODItMjAyNS0wNy0wMi1lbg==\/tiny\/Inspira-Technologies.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RA&#8217;ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Inspira\u2122 Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (&#8220;Inspira,&#8221; \u201cInspira Technologies,\u201d or the &#8220;Company&#8220;), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside the United States, in a global strategic hub, with an established track record and active commercial ties to both government entities and institutional healthcare customers. Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025. Inspira and the purchasing organization have initiated onboarding, logistics planning, and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-866133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RA&#8217;ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Inspira\u2122 Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (&#8220;Inspira,&#8221; \u201cInspira Technologies,\u201d or the &#8220;Company&#8220;), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside the United States, in a global strategic hub, with an established track record and active commercial ties to both government entities and institutional healthcare customers. Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025. Inspira and the purchasing organization have initiated onboarding, logistics planning, and &hellip; Continue reading &quot;Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-02T13:26:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase\",\"datePublished\":\"2025-07-02T13:26:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/\"},\"wordCount\":903,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/\",\"name\":\"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\",\"datePublished\":\"2025-07-02T13:26:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/","og_locale":"en_US","og_type":"article","og_title":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk","og_description":"RA&#8217;ANANA, Israel, July 02, 2025 (GLOBE NEWSWIRE) &#8212; Inspira\u2122 Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (&#8220;Inspira,&#8221; \u201cInspira Technologies,\u201d or the &#8220;Company&#8220;), a pioneer in innovative life-support and diagnostic technologies, today announced it has secured a binding $22.5 million purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside the United States, in a global strategic hub, with an established track record and active commercial ties to both government entities and institutional healthcare customers. Under the terms of the binding purchase order, full payment of $22.5 million is to be made during 2025. Inspira and the purchasing organization have initiated onboarding, logistics planning, and &hellip; Continue reading \"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-02T13:26:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase","datePublished":"2025-07-02T13:26:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/"},"wordCount":903,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/","name":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=","datePublished":"2025-07-02T13:26:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODMzMyM3MDI5NDk3IzIyMTEwMjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=866133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=866133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=866133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=866133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}